Clinical Trials Directory

Trials / Unknown

UnknownNCT01152892

Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study

Risk Stratification in End Stage Renal Disease (ISAR)

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Technical University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the use of non-invasive markers of the autonomic function and micro- and macrocirculation to predict mortality and cardiovascular end points in end-stage renal disease patients. Furthermore we aim at getting new insight into the insufficiently understood pathophysiology leading to excessively high cardiovascular and non-cardiovascular mortality in dialysis patients.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2019-05-01
Completion
2020-05-01
First posted
2010-06-29
Last updated
2016-01-26

Locations

17 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01152892. Inclusion in this directory is not an endorsement.

Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study (NCT01152892) · Clinical Trials Directory